Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Disclosure statements are available on the authors' profiles:
Comparative effectiveness of sodium-glucose co-transporter-2 inhibitors and dipeptidyl peptidase-4 inhibitors on liver function in patients with type 2 diabetes in Japan: A real-world data analysisDiabetes Obes Metab 2023 Dec 12;[EPub Ahead of Print], H Takahashi, K Asakawa, Y Kosakai, T Lee, M Rokuda
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.